Differential role and tissue specificity of interleukin-1α gene expression in atherogenesis and lipid metabolism
Abstract
Objective
We examined the role of IL-1α and IL-1β expressed by bone marrow-derived cells in atherogenesis and lipid metabolism.
Methods and results
We first studied the effect of atherogenic diet on wild-type C57BL/6 IL-1α or IL-1β deficient mice. IL-1α KO resulted in a comparatively higher total cholesterol levels, compared to WT and IL-1β KO mice (398
±
10; 266
±
19; 223
±
13
mg/dl, respectively, p
<
0.001), due to higher non-HDL cholesterol. Nevertheless, aortic sinus lesion area was 56% lower in IL-1α KO (p
<
0.05) and 50% lower in IL-1β KO (p
=
0.08), compared to WT mice. Likewise, SAA levels in IL-1α KO mice were markedly lower compared to WT and IL-1β KO mice (31
±
14; 220
±
33 and 106
±
39
μg/ml, respectively, p
<
0.001).
To study the specific role of bone marrow-derived IL-1, irradiated C57BL/6 mice were transplanted with either IL-1+/+, IL-1α−/− or IL-1β−/− bone marrow cells. Despite similar lipoprotein levels, aortic sinus lesion area was 59% lower in IL-1α−/− transplanted (p
<
0.05) compared to IL-1+/+ transplanted mice. Lesion area in IL-1β -/- was 33% lower than in IL-1+/+ recipient mice, but it was not statistically significant.
Conclusion
We demonstrated that early lesion formation is accelerated specifically by bone marrow-derived IL-1α. Furthermore, we showed that the expression of IL-1α in cells other than the bone marrow plays a significant role in non-HDL cholesterol metabolism.
Keywords: Atherosclerosis, Inflammation, Cytokines, IL-1α, IL-1β
To access this article, please choose from the options below
PII: S0021-9150(06)00700-3
doi:10.1016/j.atherosclerosis.2006.11.026
© 2006 Elsevier Ireland Ltd. All rights reserved.
